日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unmet Needs and Challenges in Cancer-Associated Venous Thromboembolism

癌症相关静脉血栓栓塞症中未满足的需求和挑战

Nusrat, Sanober; Khan, Sayeed; Beg, Kisha; Raskob, Gary

Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction Model

癌症患者复发性静脉血栓栓塞风险:个体患者数据荟萃分析及预测模型构建

Lanting, Vincent R; Takada, Toshihiko; Bosch, Floris T M; Marshall, Andrea; Grosso, Michael A; Young, Annie M; Lee, Agnes Y Y; Di Nisio, Marcello; Raskob, Gary E; Kamphuisen, Pieter W; Büller, Harry R; van Es, Nick

Advocating with Community: A Community-Engaged Advocacy Curriculum for Internal Medicine Residents

与社区携手倡导:面向内科住院医师的社区参与式倡导课程

Raskob, Kathleen; Ramanan, Radhika A; Lezak, Michael; Negrete, John E; Binder, Eleana; Addington-White, Joan; Laponis, Ryan; Griffiths, Elizabeth P

Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer

轻度血小板减少症对癌症患者出血和复发性血栓形成的影响

Patell, Rushad; Hsu, Charles; Shi, Minggao; Grosso, Michael A; Duggal, Anil; Buller, Harry R; Raskob, Gary; Zwicker, Jeffrey I

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score

长期抗凝治疗期间复发性静脉血栓栓塞和出血:VTE-PREDICT 风险评分

de Winter, Maria A; Büller, Harry R; Carrier, Marc; Cohen, Alexander T; Hansen, John-Bjarne; Kaasjager, Karin A H; Kakkar, Ajay K; Middeldorp, Saskia; Raskob, Gary E; Sørensen, Henrik T; Visseren, Frank L J; Wells, Philip S; Dorresteijn, Jannick A N; Nijkeuter, Mathilde

Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction

癌症相关血栓的治疗:最新进展、未满足的需求和未来方向

Wang, Tzu-Fei; Khorana, Alok A; Agnelli, Giancarlo; Bloomfield, Dan; Bonaca, Marc P; Büller, Harry R; Connors, Jean M; Goto, Shinya; Jing, Zhi-Cheng; Kakkar, Ajay K; Khder, Yasser; Raskob, Gary E; Soff, Gerald A; Verhamme, Peter; Weitz, Jeffrey I; Carrier, Marc

Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness

利伐沙班用于住院后长期血栓预防的获益风险评估

Raskob, Gary E; Ageno, Walter; Albers, Gregory; Elliott, C Gregory; Halperin, Jonathan; Maynard, Gregory; Steg, Philippe Gabriel; Weitz, Jeffrey I; Albanese, John; Yuan, Zhong; Levitan, Bennett; Lu, Wentao; Suh, Eun Young; Spiro, Theodore; Lipardi, Concetta; Barnathan, Elliot S; Spyropoulos, Alex C

Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population

癌症相关性静脉血栓栓塞:种族多元化人群中的发病率和特征

Raskob, Gary E; Wendelboe, Aaron M; Campbell, Janis; Ford, Lance; Ding, Kai; Bratzler, Dale W; McCumber, Micah; Adamski, Alys; Abe, Karon; Beckman, Michele G; Reyes, Nimia L; Richardson, Lisa C

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

利伐沙班联合阿司匹林用于急性重症内科患者的长期血栓预防:来自 MARINER 试验的启示

Spyropoulos, Alex C; Goldin, Mark; Ageno, Walter; Albers, Gregory W; Elliott, C Gregory; Hiatt, William R; Halperin, Jonathan L; Maynard, Gregory; Steg, P Gabriel; Weitz, Jeffrey I; Spiro, Theodore E; Lu, Wentao; Marsigliano, Jessica; Raskob, Gary E; Barnathan, Elliot S

Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study

住院心力衰竭患者的延长血栓预防:MAGELLAN 研究的事后分析

Spyropoulos, Alex C; Raskob, Gary E; Spiro, Theodore E; Lu, Wentao; De Sanctis, Yoriko; Albanese, John; Mebazaa, Alexandre; Barnathan, Elliot S